Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Sqz Biotechnologies Company
(NY:
SQZ
)
N/A
UNCHANGED
Last Price
Updated: 5:00 PM EDT, Jul 3, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Sqz Biotechnologies Company
< Previous
1
2
3
4
5
Next >
Stocks That Hit 52-Week Lows On Friday
↗
December 09, 2022
On Friday, 127 companies set new 52-week lows.
Via
Benzinga
SQZ Biotechnologies Receives FDA Fast Track Designation for its eAPC Therapeutic Candidate for Treatment of HPV16+ Tumors and Presents Clinical Data for Multiple Programs at the European Society for Medical Oncology Immuno-Oncology Congress
December 06, 2022
From
SQZ Biotechnologies Company
Via
Business Wire
US Stocks Mixed After Wednesday's Rally
↗
December 01, 2022
U.S. stocks traded mixed this morning, with the Dow Jones falling around 180 points on Thursday.
Via
Benzinga
Expert Ratings for SQZ Biotechnologies
↗
December 01, 2022
Via
Benzinga
Analyst Ratings for SQZ Biotechnologies
↗
December 01, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
↗
December 02, 2022
On Friday, 72 companies hit new 52-week lows.
Via
Benzinga
SQZ Biotechnologies Announces Strategic Prioritization of SQZ® Enhanced Antigen Presenting Cells Program; Armon Sharei to Step Down as Chief Executive Officer
November 30, 2022
From
SQZ Biotechnologies
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For December 2, 2022
↗
December 02, 2022
Via
Benzinga
SQZ Biotechnologies Presents Cell Squeeze® Manufacturing Platform, Linked Antigen mRNA Preclinical Research, and COMMANDER-001 Phase 1/2 Clinical Trial in Progress Poster at Society for Immunotherapy of Cancer Annual Meeting
November 10, 2022
From
SQZ Biotechnologies
Via
Business Wire
Why Dollar General Shares Are Trading Lower By Over 8%? Here Are 60 Stocks Moving In Thursday's Mid-Day Session
↗
December 01, 2022
Gainers Top Ships Inc. (NASDAQ: TOPS) shares jumped 74% to $5.24. Vapotherm, Inc. (NASDAQ: VAPO) gained 48.8% to $1.3250.
Via
Benzinga
SQZ Biotechnologies Reports Third Quarter 2022 Financial Results and Recent Portfolio Updates
November 09, 2022
From
SQZ Biotechnologies
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For December 1, 2022
↗
December 01, 2022
Via
Benzinga
Analyst Bullish On SQZ Biotech's Technology For Solving Cell Therapy Challenges
↗
October 20, 2022
Via
Benzinga
SQZ Biotechnologies Publishes Preclinical Research Demonstrating SQZ® AAC Platform’s Potential as an Effective Red Blood Cell-Derived Immunotherapy
October 03, 2022
From
SQZ Biotechnologies Company
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For October 20, 2022
↗
October 20, 2022
Upgrades
Via
Benzinga
SQZ Biotechnologies Presents Preclinical SQZ® TIL Data Supporting Potential Ability of mRNA-Driven IL-2 and IL-12 Expression to Eliminate Need for Toxic Preconditioning and Systemic IL-2 Administration for Certain T Cell Therapies
September 12, 2022
From
SQZ Biotechnologies Company
Via
Business Wire
SQZ Biotechnologies to Present at Upcoming Investor Conferences
September 07, 2022
From
SQZ Biotechnologies Company
Via
Business Wire
SQZ Biotechnologies Announces Leadership Transition
September 06, 2022
From
SQZ Biotechnologies Company
Via
Business Wire
SQZ Biotechnologies Reports Second Quarter 2022 Financial Results and Recent Portfolio Updates
August 04, 2022
From
SQZ Biotechnologies
Via
Business Wire
Stocks That Hit 52-Week Lows On Monday
↗
August 01, 2022
On Monday, 92 companies set new 52-week lows.
Via
Benzinga
SQZ Biotechnologies and Collaborators Publish Technology Review on SQZ® APCs and Effective CD8 T Cell Activation
July 12, 2022
From
SQZ Biotechnologies Company
Via
Business Wire
The Daily Biotech Pulse: GSK To Supply 50M Flu Vaccine Doses To US, FDA Lifts Hold On Greenwich's Cancer Immunotherapy Trial, Connect Biopharma Sees CBP-201 Topline Data Sooner
↗
July 12, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
SQZ Biotechnologies Appoints Micah Zajic as Chief Financial Officer
July 11, 2022
From
SQZ Biotechnologies
Via
Business Wire
SQZ Biotechnologies Presents Celiac Disease Tolerizing Antigen Carrier Preclinical Data at 2022 Federation of Clinical Immunology Societies (FOCIS) Annual Meeting
June 21, 2022
From
SQZ Biotechnologies Company
Via
Business Wire
SQZ Biotechnologies Announces Generation of Dopaminergic Neurons from Human Pluripotent Stem Cells Through Single-Step Delivery of Six Cell-Fate Encoding RNAs
June 16, 2022
From
SQZ Biotechnologies Company
Via
Business Wire
Looking Into SQZ Biotechnologies's Return On Capital Employed
↗
June 14, 2022
SQZ Biotechnologies (NYSE:SQZ) brought in sales totaling $2.87 million during Q1 according to data provided by Benzinga Pro. However, earnings decreased 77.96%, resulting in a loss of $21.04 million.
Via
Benzinga
SQZ Biotechnologies to Present at Jefferies Healthcare Conference
June 01, 2022
From
SQZ Biotechnologies
Via
Business Wire
SQZ Biotechnologies Appoints Marshelle Smith Warren, M.D., as Chief Medical Officer
May 31, 2022
From
SQZ Biotechnologies
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For May 25, 2022
↗
May 25, 2022
Upgrades Credit Suisse upgraded the previous rating for Molecular Partners AG (NASDAQ:MOLN) from Underperform to Neutral. NoneAt the moment, the stock has a 52-week-high of $32.04 and a 52-week-low of...
Via
Benzinga
SQZ Biotechnologies Announces Integrated Point-of-Care Cell Therapy Manufacturing System Demonstrated Comparable or Better Performance Than a More Conventional Clean Room-Based Process
May 18, 2022
From
SQZ Biotechnologies
Via
Business Wire
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
